Natco Pharma has received tentative approval from application from US Food & Drug Administration (US FDA) for the drug, Anastrozole. The drug would be available in the tablet form in the strength of 1 mg.

 

Anastrozole is a drug indicated in the treatment of breast cancer in post-menopausal women. Natco Pharma is engaged in manufacturing and marketing pharmaceutical substances and finished dosage forms.